This page shows the latest Evoq Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Companies will collaborate on novel drugs for autoimmune disorders. Amgen has entered into a license and collaboration agreement with Evoq Therapeutics worth over $240m, with the aim of developing novel drugs ... In a preclinical ‘gold-standard’
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...